skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: ClinicalKey remover Base de dados/Biblioteca: Publisher or Other Site remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy
Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy

Worm, Margitta, MD ; Lee, Hae-Hyuk, MD ; Kleine-Tebbe, Jörg, MD ; Hafner, Roderick P., PhD ; Laidler, Paul, PhD ; Healey, David, MSc ; Buhot, Cecile, PhD ; Verhoef, Adrienne, PhD ; Maillère, Bernard, PhD ; Kay, A. Barry, MD, PhD ; Larché, Mark, PhD

Journal of allergy and clinical immunology, 2011-01, Vol.127 (1), p.89-97.e14 [Periódico revisado por pares]

New York, NY: Mosby, Inc

Texto completo disponível

Citações Citado por
2
Fel d 1–derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study
Fel d 1–derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fel d 1–derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study

Patel, Deepen, MD ; Couroux, Peter, MD ; Hickey, Pascal, PhD ; Salapatek, Anne Marie, PhD ; Laidler, Paul, PhD ; Larché, Mark, PhD ; Hafner, Roderick P., PhD

Journal of allergy and clinical immunology, 2013-01, Vol.131 (1), p.103-109.e7 [Periódico revisado por pares]

New York, NY: Mosby, Inc

Texto completo disponível

Citações Citado por
3
Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes
Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes

Hafner, R.P ; Salapatek, A ; Patel, D ; Larché, M ; Laidler, P

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB368-AB368 [Periódico revisado por pares]

Mosby, Inc

Texto completo disponível

Citações Citado por
4
Development and Preliminary Clinical Evaluation of a Peptide Immunotherapy Vaccine for Cat Allergy
Development and Preliminary Clinical Evaluation of a Peptide Immunotherapy Vaccine for Cat Allergy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Development and Preliminary Clinical Evaluation of a Peptide Immunotherapy Vaccine for Cat Allergy

Larché, M ; Lee, H ; Kleine-Tebbe, J ; Hafner, R.P ; Laidler, P ; Healey, D ; Buhot, C ; Verhoef, A ; Maillère, B ; Kay, A.B ; Worm, M

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB219-AB219 [Periódico revisado por pares]

St. Louis: Mosby, Inc

Texto completo disponível

Citações Citado por
5
Pineal germinoma with syncytiotrophoblastic giant cells: A case with panhypopituitarism and isosexual pseudopuberty
Pineal germinoma with syncytiotrophoblastic giant cells: A case with panhypopituitarism and isosexual pseudopuberty
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pineal germinoma with syncytiotrophoblastic giant cells: A case with panhypopituitarism and isosexual pseudopuberty

Laidler, Peter ; Pounder, Derrick J.

Human pathology, 1984-03, Vol.15 (3), p.285-287 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.